Cefminox (INN) is a second-generation cephalosporin antibiotic.[1][2]
Spectrum
Cefminox is a broad-spectrum, bactericidal cephalosporin antibiotic. It is especially effective against Gram-negative and anaerobic bacteria. [citation needed]The following represents MIC data for a few medically significant microorganisms.
- Clostridium difficile: 2 - 4 μg/ml
- Escherichia coli: 0.125 - 16 μg/ml
- Pseudomonas aeruginosa: 256 μg/ml[3]
References
- ^ Torres AJ, Valladares LD, Jover JM, Sánchez-Pernaute A, Frías J, Carcas AJ, et al. (September 2000). "Cefminox versus metronidazole plus gentamicin intra-abdominal infections: a prospective randomized controlled clinical trial". Infection. 28 (5): 318–22. doi:10.1007/s150100070027. PMID 11073141. S2CID 41555982.
- ^ US 8497086, "Reaction Medium For Methicillin-Resistant Staphylococcus Aureus (MRSA) Bacteria", issued 20 July 2013, assigned to Biomereux
- ^ "Cefminox sodium Susceptibility and Minimum Inhibitory Concentration (MIC) Data" (PDF). www.toku-e.com.